The image below demonstrates the effects of GLP-1 agonists on various systems: The most common adverse drug reactions reported with GLP-1 agonists are as follows: These include: In New Zealand, dulaglutide (Trulicity) was the first approved GLP-1 agonist, made available for the treatment of Type 2 Diabetes in 2021
Mitochondria in Alzheimer brains
Its used to treat several skin diseases that are connected to inflammation including atopic dermatitis, rosacea or eczema
L-carnitine is an amino acid that has been shown to help facilitate the transfer of fatty acids into the mitochondria of cells for energy production
Well-controlled DM2 (A1C ~7 for the past 3 years or so) on Rybelsus - last dose was ~32 hours before induction
Healthy Fats : Avocados, nuts (almonds, pistachios, peanuts), seeds, olive oil